CPTx
Planegg
About CPTx
CPTx develops single-stranded DNA products to neutralize viruses and address infectious diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $29.0M
- Last round: Series Unknown (Sep 2024)
- Website: cptx.bio
- Phone: +49 089 6933 0382
Industries & Categories
Biotechnology, Genetics, Test and Measurement
Social Profiles
Canonical: https://fsome.com/organization/cptx-47418 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.